First line EXE (epirubicin, capecitabine and oxaliplatin) is a highly active and convenient out-patients regimen in patients with non-resectable gastric cancer

Katrine Schønnemann, Benny Vittrup Jensen, Mette Yilmaz, Jon Kroll Bjerregaard, Helle Anita Jensen, Kirsten Vistisen, Per Pfeiffer

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

OriginalsprogEngelsk
Publikationsdato2008
StatusUdgivet - 2008
BegivenhedAmerican Society of Clinical Oncology - 2008 Gastrointestinal Cancers - Orlando, USA
Varighed: 25. jan. 200827. jan. 2008

Konference

KonferenceAmerican Society of Clinical Oncology - 2008 Gastrointestinal Cancers
LandUSA
ByOrlando
Periode25/01/200827/01/2008

Citationsformater